{"id":24592,"date":"2022-11-07T01:13:00","date_gmt":"2022-11-06T17:13:00","guid":{"rendered":"https:\/\/flcube.com\/?p=24592"},"modified":"2025-02-01T01:18:39","modified_gmt":"2025-01-31T17:18:39","slug":"ciie-met-her2-precision-diagnosis-alliance-formed-to-advance-lung-cancer-treatment","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=24592","title":{"rendered":"CIIE: MET HER2 Precision Diagnosis Alliance Formed to Advance Lung Cancer Treatment"},"content":{"rendered":"\n<p>The 5th China International Import Expo (CIIE) witnessed the establishment of the MET HER2 precision diagnosis alliance, a collaborative initiative involving AstraZeneca, Daiichi Sankyo, HutchMed, Roche Diagnostics, AmoyDx, LBP Medicine, Deep Informatics, Histo Medical Pathological Diagnosis Center, Rightongene Bio, and Genetron. This alliance aims to enhance the implementation of HER2 targeting novel diagnosis plans in China.<\/p>\n\n\n\n<p><strong>Daiichi Sankyo&#8217;s Commitment<\/strong><br>Daiichi Sankyo, an important member of the alliance based in Japan, has pledged to boost the implementation of HER2 targeting novel diagnosis plans in China alongside other members. This commitment underscores the alliance&#8217;s focus on improving clinical outcomes for patients with HER2-mutated non-small cell lung cancer (NSCLC).<\/p>\n\n\n\n<p><strong>HER2 Mutation and Clinical Need<\/strong><br>HER2 mutation, one of the driving genes associated with non-small cell lung cancer (NSCLC), is closely related to a poor prognosis in patients. This makes the development of effective clinical treatments an urgent need. The alliance aims to address this challenge by advancing innovative diagnostic solutions.<\/p>\n\n\n\n<p><strong>Enhertu&#8217;s Regulatory Progress<\/strong><br>Daiichi\/AstraZeneca&#8217;s HER2-targeted antibody drug conjugate (ADC) Enhertu (trastuzumab deruxtecan) was fast-tracked to approval in the US in August this year for the treatment of adult patients with unresectable or metastatic HER2-mutated NSCLC previously treated with systemic therapy. The drug is currently under regulatory review in China, highlighting the alliance&#8217;s potential impact on the global treatment landscape for HER2-mutated cancers.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The 5th China International Import Expo (CIIE) witnessed the establishment of the MET HER2 precision&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[1130,130,16,194,2112,83,285,960,478,291],"class_list":["post-24592","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-amoydx","tag-astrazeneca","tag-cancer","tag-daiichi-sankyo","tag-genetron","tag-her2","tag-hutchmed","tag-lbp-medicine","tag-rightongene-biotechnology","tag-roche-diagnostics"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>CIIE: MET HER2 Precision Diagnosis Alliance Formed to Advance Lung Cancer Treatment - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"The 5th China International Import Expo (CIIE) witnessed the establishment of the MET HER2 precision diagnosis alliance, a collaborative initiative involving AstraZeneca, Daiichi Sankyo, HutchMed, Roche Diagnostics, AmoyDx, LBP Medicine, Deep Informatics, Histo Medical Pathological Diagnosis Center, Rightongene Bio, and Genetron. This alliance aims to enhance the implementation of HER2 targeting novel diagnosis plans in China.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=24592\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CIIE: MET HER2 Precision Diagnosis Alliance Formed to Advance Lung Cancer Treatment\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=24592\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-06T17:13:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-31T17:18:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=24592#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=24592\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"CIIE: MET HER2 Precision Diagnosis Alliance Formed to Advance Lung Cancer Treatment\",\"datePublished\":\"2022-11-06T17:13:00+00:00\",\"dateModified\":\"2025-01-31T17:18:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=24592\"},\"wordCount\":245,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"AmoyDx\",\"AstraZeneca\",\"Cancer\",\"Daiichi Sankyo\",\"Genetron\",\"HER2\",\"HutchMed\",\"LBP Medicine\",\"Rightongene Biotechnology\",\"Roche Diagnostics\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=24592#respond\"]}],\"copyrightYear\":\"2022\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=24592\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=24592\",\"name\":\"CIIE: MET HER2 Precision Diagnosis Alliance Formed to Advance Lung Cancer Treatment - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2022-11-06T17:13:00+00:00\",\"dateModified\":\"2025-01-31T17:18:39+00:00\",\"description\":\"The 5th China International Import Expo (CIIE) witnessed the establishment of the MET HER2 precision diagnosis alliance, a collaborative initiative involving AstraZeneca, Daiichi Sankyo, HutchMed, Roche Diagnostics, AmoyDx, LBP Medicine, Deep Informatics, Histo Medical Pathological Diagnosis Center, Rightongene Bio, and Genetron. This alliance aims to enhance the implementation of HER2 targeting novel diagnosis plans in China.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=24592#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=24592\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=24592#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CIIE: MET HER2 Precision Diagnosis Alliance Formed to Advance Lung Cancer Treatment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"CIIE: MET HER2 Precision Diagnosis Alliance Formed to Advance Lung Cancer Treatment - Insight, China&#039;s Pharmaceutical Industry","description":"The 5th China International Import Expo (CIIE) witnessed the establishment of the MET HER2 precision diagnosis alliance, a collaborative initiative involving AstraZeneca, Daiichi Sankyo, HutchMed, Roche Diagnostics, AmoyDx, LBP Medicine, Deep Informatics, Histo Medical Pathological Diagnosis Center, Rightongene Bio, and Genetron. This alliance aims to enhance the implementation of HER2 targeting novel diagnosis plans in China.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=24592","og_locale":"en_US","og_type":"article","og_title":"CIIE: MET HER2 Precision Diagnosis Alliance Formed to Advance Lung Cancer Treatment","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=24592","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2022-11-06T17:13:00+00:00","article_modified_time":"2025-01-31T17:18:39+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=24592#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=24592"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"CIIE: MET HER2 Precision Diagnosis Alliance Formed to Advance Lung Cancer Treatment","datePublished":"2022-11-06T17:13:00+00:00","dateModified":"2025-01-31T17:18:39+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=24592"},"wordCount":245,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["AmoyDx","AstraZeneca","Cancer","Daiichi Sankyo","Genetron","HER2","HutchMed","LBP Medicine","Rightongene Biotechnology","Roche Diagnostics"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=24592#respond"]}],"copyrightYear":"2022","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=24592","url":"https:\/\/flcube.com\/?p=24592","name":"CIIE: MET HER2 Precision Diagnosis Alliance Formed to Advance Lung Cancer Treatment - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2022-11-06T17:13:00+00:00","dateModified":"2025-01-31T17:18:39+00:00","description":"The 5th China International Import Expo (CIIE) witnessed the establishment of the MET HER2 precision diagnosis alliance, a collaborative initiative involving AstraZeneca, Daiichi Sankyo, HutchMed, Roche Diagnostics, AmoyDx, LBP Medicine, Deep Informatics, Histo Medical Pathological Diagnosis Center, Rightongene Bio, and Genetron. This alliance aims to enhance the implementation of HER2 targeting novel diagnosis plans in China.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=24592#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=24592"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=24592#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"CIIE: MET HER2 Precision Diagnosis Alliance Formed to Advance Lung Cancer Treatment"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/24592","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=24592"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/24592\/revisions"}],"predecessor-version":[{"id":24593,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/24592\/revisions\/24593"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=24592"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=24592"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=24592"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}